Correlation Between Catalyst Pharmaceuticals and Amylyx Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and Amylyx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and Amylyx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Catalyst Pharmaceuticals and Amylyx Pharmaceuticals, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and Amylyx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of Amylyx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and Amylyx Pharmaceuticals.

Diversification Opportunities for Catalyst Pharmaceuticals and Amylyx Pharmaceuticals

-0.66

Correlation Coefficient

Catalyst Pharmaceuticals  Amylyx Pharmaceuticals

Excellent diversification

The 3 months correlation between Catalyst and Amylyx is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and Amylyx Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amylyx Pharmaceuticals and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with Amylyx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amylyx Pharmaceuticals has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and Amylyx Pharmaceuticals go up and down completely randomly.

Pair Corralation between Catalyst Pharmaceuticals and Amylyx Pharmaceuticals

Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to under-perform the Amylyx Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Catalyst Pharmaceuticals is 2.87 times less risky than Amylyx Pharmaceuticals. The stock trades about -0.06 of its potential returns per unit of risk. The Amylyx Pharmaceuticals is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  536.00  in Amylyx Pharmaceuticals on April 25, 2025 and sell it today you would earn a total of  303.00  from holding Amylyx Pharmaceuticals or generate 56.53% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Catalyst Pharmaceuticals  vs.  Amylyx Pharmaceuticals

Catalyst Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Catalyst Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Amylyx Pharmaceuticals

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Amylyx Pharmaceuticals are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating essential indicators, Amylyx Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Catalyst Pharmaceuticals and Amylyx Pharmaceuticals

The main advantage of trading using opposite Catalyst Pharmaceuticals and Amylyx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, Amylyx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amylyx Pharmaceuticals will offset losses from the drop in Amylyx Pharmaceuticals' long position.

The idea behind Catalyst Pharmaceuticals and Amylyx Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.